{"title":"偏头痛:流行病学和合并症。","authors":"R B Lipton, W F Stewart","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Migraine imposes substantial burdens both on individual headache sufferers and on society. Prevalence studies reveal that the condition affects about 18% of women and about 6% of men. Prevalence is highest between the ages of 25 and 55, during the peak productive years. Despite the development of new and effective treatment options, migraine remains an underdiagnosed and undertreated condition. In this article, we review the incidence, prevalence, and distribution of migraine and the conditions which are comorbid with migraine.</p>","PeriodicalId":79395,"journal":{"name":"Clinical neuroscience (New York, N.Y.)","volume":"5 1","pages":"2-9"},"PeriodicalIF":0.0000,"publicationDate":"1998-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Migraine headaches: epidemiology and comorbidity.\",\"authors\":\"R B Lipton, W F Stewart\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Migraine imposes substantial burdens both on individual headache sufferers and on society. Prevalence studies reveal that the condition affects about 18% of women and about 6% of men. Prevalence is highest between the ages of 25 and 55, during the peak productive years. Despite the development of new and effective treatment options, migraine remains an underdiagnosed and undertreated condition. In this article, we review the incidence, prevalence, and distribution of migraine and the conditions which are comorbid with migraine.</p>\",\"PeriodicalId\":79395,\"journal\":{\"name\":\"Clinical neuroscience (New York, N.Y.)\",\"volume\":\"5 1\",\"pages\":\"2-9\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1998-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical neuroscience (New York, N.Y.)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical neuroscience (New York, N.Y.)","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Migraine imposes substantial burdens both on individual headache sufferers and on society. Prevalence studies reveal that the condition affects about 18% of women and about 6% of men. Prevalence is highest between the ages of 25 and 55, during the peak productive years. Despite the development of new and effective treatment options, migraine remains an underdiagnosed and undertreated condition. In this article, we review the incidence, prevalence, and distribution of migraine and the conditions which are comorbid with migraine.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
